Saudi Central Bank raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 85.8% in the 2nd quarter, Holdings Channel reports. The firm owned 10,955 shares of the company’s stock after acquiring an additional 5,059 shares during the period. Saudi Central Bank’s holdings in HCA Healthcare were worth $4,271,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the business. Palisade Asset Management LLC acquired a new stake in HCA Healthcare in the third quarter valued at about $26,000. MidFirst Bank bought a new position in shares of HCA Healthcare in the second quarter worth about $28,000. Clearstead Trust LLC bought a new stake in shares of HCA Healthcare during the 2nd quarter valued at approximately $29,000. JPL Wealth Management LLC bought a new position in HCA Healthcare in the 3rd quarter valued at approximately $33,000. Finally, Cedar Mountain Advisors LLC bought a new stake in shares of HCA Healthcare during the first quarter worth $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.
Analysts Set New Price Targets
HCA has been the topic of several recent research reports. JPMorgan Chase & Co. cut their price objective on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a report on Thursday, August 20th. Truist Financial dropped their target price on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research report on Monday, July 27th. TD Cowen dropped their price objective on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Weiss Ratings cut shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. Finally, UBS Group cut their price target on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a report on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $462.64.
HCA Healthcare Price Performance
Shares of HCA stock opened at $404.95 on Monday. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The business’s 50 day simple moving average is $403.35 and its 200 day simple moving average is $436.82. The stock has a market capitalization of $87.67 billion, a PE ratio of 13.56, a PEG ratio of 1.33 and a beta of 1.10.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the previous year, the company earned $6.84 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. As a group, research analysts expect that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.
HCA Healthcare Company Profile
HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
- Five stocks we like better than HCA Healthcare
- AI Token Costs Are Changing the Hardware vs. Software Debate
- 3 ETFs That Could Move as Rate Expectations Shift
- 3 Stocks With September Catalysts Investors Shouldn’t Ignore
- Ollie’s Bargain Outlet Stock Falls on Weak Comps Despite Margin Gains
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
